Skip to main content

Published locations for Extended-interval dosing of natalizumab linked to lower risk of PML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Extended-interval dosing of natalizumab linked to lower risk of PML

User login

  • Reset your password
  • /content/extended-interval-dosing-natalizumab-linked-lower-risk-pml
  • /multiplesclerosishub/article/159277/multiple-sclerosis/extended-interval-dosing-natalizumab-linked
  • /neurology/article/159277/multiple-sclerosis/extended-interval-dosing-natalizumab-linked-lower-risk
  • /neurology/msresourcecenter/article/159277/multiple-sclerosis/extended-interval-dosing-natalizumab
  • /breast-cancer-icymi/article/159277/multiple-sclerosis/extended-interval-dosing-natalizumab-linked
  • /b-cell-lymphoma-icymi/article/159277/multiple-sclerosis/extended-interval-dosing-natalizumab-linked
  • /clinicalneurologynews/article/159277/multiple-sclerosis/extended-interval-dosing-natalizumab-linked